FPN || Digestive Disorders

Teamwork, technology improve hepatitis C rural care

Posted on: 08/05/2014 - 18:15

Communication and collaborative use of technology by physicians who serve underserved populations and by specialists can enhance patient management and treatment of hepatitis C virus infection,...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: PCPs fuzzy on HCC surveillance in cirrhosis

Posted on: 08/05/2014 - 17:00

CHICAGO – Several medical societies recommend that patients with cirrhosis undergo ultrasound surveillance for hepatocellular carcinoma every 6 months, but studies suggest less than 20% receive...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: GERD may boost increase heart attack risk

Posted on: 08/05/2014 - 16:45

CHICAGO – Gastroesophageal reflux disease may constitute a heretofore unrecognized risk factor for coronary heart disease. In a nationwide case-control study of prodigious proportions,...

Field of Interest: Cardiology
Type: News Item

VIDEO: GERD may boost increase heart attack risk

Posted on: 08/05/2014 - 16:45

CHICAGO – Gastroesophageal reflux disease may constitute a heretofore unrecognized risk factor for coronary heart disease. In a nationwide case-control study of prodigious proportions,...

Field of Interest: Gastroentero...
Type: News Item

RM-131 makes headway against diabetic gastroparesis

Posted on: 07/05/2014 - 21:40

CHICAGO – The investigational ghrelin agonist RM-131 significantly improved gastric emptying and vomiting in patients with diabetic gastroparesis in a phase II, double-blind study. Gastric emptying...

Field of Interest: Gastroentero...
Type: News Item

RM-131 makes headway against diabetic gastroparesis

Posted on: 07/05/2014 - 21:40

CHICAGO – The investigational ghrelin agonist RM-131 significantly improved gastric emptying and vomiting in patients with diabetic gastroparesis in a phase II, double-blind study. Gastric emptying...

Field of Interest: Endocrinology
Type: News Item

Interferon-free regimen improves response in HCV

Posted on: 05/05/2014 - 21:25

CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More